UnitedHealth Group (NYSE:UNH) Posts Earnings Results

UnitedHealth Group (NYSE:UNH) issued its quarterly earnings results on Thursday. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09), RTT News reports. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $109.58 billion during the quarter, compared to analysts’ expectations of $111.56 billion. During the same period in the previous year, the company earned $6.91 earnings per share. UnitedHealth Group updated its FY 2025 guidance to 26.000-26.500 EPS.

UnitedHealth Group Price Performance

Shares of UNH stock opened at $456.10 on Friday. UnitedHealth Group has a twelve month low of $438.50 and a twelve month high of $630.73. The stock has a fifty day simple moving average of $514.51 and a two-hundred day simple moving average of $541.53. The stock has a market capitalization of $417.20 billion, a price-to-earnings ratio of 29.43, a P/E/G ratio of 1.37 and a beta of 0.61. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were issued a $2.10 dividend. The ex-dividend date was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.84%. UnitedHealth Group’s payout ratio is 54.19%.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in UnitedHealth Group stock. Revolve Wealth Partners LLC grew its position in UnitedHealth Group Incorporated (NYSE:UNH) by 137.1% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 4,019 shares of the healthcare conglomerate’s stock after buying an additional 2,324 shares during the period. Revolve Wealth Partners LLC’s holdings in UnitedHealth Group were worth $2,033,000 at the end of the most recent quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on UNH shares. HSBC upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price target on the stock in a research note on Friday, January 10th. Mizuho upped their target price on shares of UnitedHealth Group from $600.00 to $650.00 and gave the company an “outperform” rating in a report on Wednesday, April 9th. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Thursday, January 23rd. Piper Sandler cut their target price on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research report on Thursday, January 2nd. Finally, Barclays dropped their target price on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research report on Friday, January 17th. Twenty-one investment analysts have rated the stock with a buy rating and three have issued a strong buy rating to the company. Based on data from MarketBeat, UnitedHealth Group currently has an average rating of “Buy” and an average target price of $632.85.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.